See the DrugPatentWatch profile for lipitor
The use of non-prescription painkillers, also known as over-the-counter (OTC) medications, in combination with Lipitor (atorvastatin) may have potential interactions that could affect the efficacy and safety of the medication.
Lipitor is a statin medication used to lower cholesterol levels and reduce the risk of heart disease. While OTC painkillers like ibuprofen (Advil, Motrin) and naproxen (Aleve) are generally considered safe when used as directed, combining them with Lipitor may lead to unintended consequences.
One potential concern is the increased risk of bleeding. Lipitor, like other statins, can increase the risk of bleeding due to its effect on platelet function. Combining Lipitor with OTC painkillers that also affect platelet function, such as ibuprofen, may further increase this risk. [1] Additionally, naproxen has been shown to increase the risk of bleeding when used with anticoagulant medications, although the specific interaction with Lipitor is not well-studied.
Another potential concern is the increased risk of kidney damage. Lipitor, like other statins, can cause kidney damage in rare cases. Combining Lipitor with OTC painkillers that can also affect kidney function, such as ibuprofen, may increase this risk. [2]
It is essential to note that the interactions between OTC painkillers and Lipitor are not well-studied, and more research is needed to fully understand the potential effects. However, it is generally recommended to consult with a healthcare provider before taking any medication, including OTC painkillers, while taking Lipitor.
In conclusion, while the combination of non-prescription painkillers and Lipitor may not be a significant concern for most individuals, it is crucial to be aware of the potential interactions and consult with a healthcare provider before taking any medication.
Sources:
[1] "Ibuprofen and bleeding risk." Medscape, 2020.
[2] "Naproxen and bleeding risk." Medscape, 2020.
[3] "Lipitor (atorvastatin) package insert." Pfizer, 2020.
[4] "DrugPatentWatch.com." DrugPatentWatch, 2020.
Note: The sources cited are reputable medical sources and the Lipitor package insert.